Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

VivoSim Labs, INC.

NASDAQ: VIVS · Life Sciences · 3 alerts · CIK 1497253

Share price
$0.1237Close, Nov 16
Market cap
$2.51M
Shares outstanding
20.28MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All VivoSim Labs, INC. filings on SEC EDGAR ↗

4:09 PM ET 10-Q
Financial Results

VivoSim Labs Q2 2026 Results: Net Loss of $475K, Loss Narrows

VivoSim Labs reported a net loss of $1.8 million for the six months ended September 30, 2026, a significant improvement from the $5.4 million loss in the prior year period, primarily due to a $5.0 million milestone payment gain. The company transitioned its business model toward 3D human tissue model testing services following FDA regulatory shifts, while significantly increasing its outstanding share count from 2.9 million to 18.1 million during the period.

Key figure
Net loss $475K

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.